Destiny Pharma (DEST)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

58.50p
   
  • Change Today:
    -1.50p
  • 52 Week High: 91.00
  • 52 Week Low: 29.50
  • Currency: UK Pounds
  • Shares Issued: 73.31m
  • Volume: 39,534
  • Market Cap: £42.88m
  • RiskGrade: 410

Destiny Pharma Overview

Destiny Pharma, a clinical stage biotechnology company focused on the development of novel anti-microbial drugs, which address the global problem of anti-microbial resistance (AMR).

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn n/a -20308.2%
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue n/a 1286.6
Pr/Book 5.7  
Latest F'cast
Revenue n/a n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Destiny Pharma Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-17 n/a (3.21) (8.37)p n/a n/a n/a n/a 0.0%
31-Dec-18 n/a (6.01) (11.85)p n/a n/a n/a n/a 0.0%
31-Dec-19 n/a (5.52) (10.66)p n/a n/a n/a n/a 0.0%
31-Dec-20 n/a (6.48) (12.00)p n/a n/a n/a n/a 0.0%
31-Dec-21 n/a (6.27) (8.90)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Destiny Pharma Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-22 0.03 (6.77) (9.49)p n/a n/a n/a n/a 0.0%
31-Dec-23 0.10 (6.40) (9.30)p n/a n/a n/a n/a 0.0%
31-Dec-24 0.10 (9.90) (14.85)p n/a n/a n/a n/a 0.0%

Copyright © 2023 FactSet Research Systems Inc. All rights reserved.

Destiny Pharma Company Announcements

Exercise of Options and Total Voting Rights 26-Jan-2023 10:10 RNS
Second Price Monitoring Extn 22-Dec-2022 09:05 RNS
Price Monitoring Extension 22-Dec-2022 09:00 RNS

Destiny Pharma ShareCast News

Destiny Pharma jumps on 2022 progress 22-Dec-2022 ShareCast
Destiny Pharma finalises plans for next study of... 07-Dec-2022 ShareCast
Destiny Pharma starts new safety study of dermal... 15-Nov-2022 ShareCast

Latest Destiny Pharma Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Destiny Pharma Market Data

Currency UK Pounds
Share Price 58.50p
Change Today -1.50p
% Change -2.50 %
52 Week High 91.00
52 Week Low 29.50
Volume 39,534
Shares Issued 73.31m
Market Cap £42.88m
RiskGrade 410

Destiny Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
39.01% below the market average39.01% below the market average39.01% below the market average39.01% below the market average39.01% below the market average
68.42% below the sector average68.42% below the sector average68.42% below the sector average68.42% below the sector average68.42% below the sector average
Price Trend
13.75% below the market average13.75% below the market average13.75% below the market average13.75% below the market average13.75% below the market average
47.54% above the sector average47.54% above the sector average47.54% above the sector average47.54% above the sector average47.54% above the sector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 0
Buy 1
Neutral 0
Sell 0
Strong Sell 0
Total 1
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Destiny Pharma Dividends

No dividends found

Trades for 27-Jan-2023

Time Volume / Share Price
16:35 3 @ 59.00p
16:35 486 @ 58.00p
15:20 8,628 @ 58.00p
15:19 5,000 @ 58.68p
15:18 2,320 @ 58.00p

Destiny Pharma Key Personnel

CEO Neil Clark
Chair Nick Rodgers

Top of Page